SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Nov-22 5:04 PM View: | Verve Therapeutics, Inc. (VERV) | 04-Nov-22 | Disposition (other) | 48,583 | -- | -- | (< 1%) 10.51M to 10.47M | |
08-Nov-22 5:04 PM View: | Verve Therapeutics, Inc. (VERV) | 04-Nov-22 | Sale (Planned) | 97,166 | $31.14 | $3,025,610.00 | (< 1%) 10.47M to 10.37M | |
04-Nov-22 4:16 PM View: | Verve Therapeutics, Inc. (VERV) | 03-Nov-22 | Disposition (other) | 49,569 | -- | -- | (< 1%) 10.61M to 10.56M | |
04-Nov-22 4:16 PM View: | Verve Therapeutics, Inc. (VERV) | 03-Nov-22 | Sale (Planned) | 99,137 | $32.79 | $3,251,030.00 | (< 1%) 10.56M to 10.47M | |
04-Nov-22 4:16 PM View: | Verve Therapeutics, Inc. (VERV) | 02-Nov-22 | Disposition (other) | 28,651 | -- | -- | (< 1%) 10.65M to 10.62M | |
04-Nov-22 4:16 PM View: | Verve Therapeutics, Inc. (VERV) | 02-Nov-22 | Sale (Planned) | 57,303 | $35.94 | $2,059,630.00 | (< 1%) 10.62M to 10.56M | |
02-Nov-22 4:25 PM View: | Verve Therapeutics, Inc. (VERV) | 01-Nov-22 | Disposition (other) | 31,963 | -- | -- | (< 1%) 10.72M to 10.69M | |
02-Nov-22 4:25 PM View: | Verve Therapeutics, Inc. (VERV) | 01-Nov-22 | Sale (Planned) | 63,926 | $36.79 | $2,351,710.00 | (< 1%) 10.69M to 10.62M | |
02-Nov-22 4:25 PM View: | Verve Therapeutics, Inc. (VERV) | 31-Oct-22 | Disposition (other) | 53,697 | -- | -- | (< 1%) 10.85M to 10.79M | |
02-Nov-22 4:25 PM View: | Verve Therapeutics, Inc. (VERV) | 31-Oct-22 | Sale (Planned) | 107,393 | $38.64 | $4,149,330.00 | (< 1%) 10.79M to 10.69M | |
22-Jun-21 5:20 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Conversion | 6,320,900 | -- | -- | 100% 0 to 6.32M | |
17-Feb-21 7:42 PM View: | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 494,649 | -- | -- | 100% 0 to 494.65K | |
19-Mar-18 5:28 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Mar-18 | Conversion | 1,924,470 | -- | -- | 100% 0 to 1.92M |